These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9173677)

  • 21. [Epidemiology of the HIV infection].
    Jablonowski H; Jablonowski B
    MMW Fortschr Med; 2009 Apr; 151(18):32-3. PubMed ID: 19769070
    [No Abstract]   [Full Text] [Related]  

  • 22. Women and AIDS--unexplained higher risk of death.
    AIDS Treat News; 1995 Jan; (No 214):2-3. PubMed ID: 11362185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of new antiretroviral regimes on HIV-associated hospital admissions and deaths.
    Domingo P; Guardiola JM; Ris J; Nolla J
    AIDS; 1998 Mar; 12(5):529-30. PubMed ID: 9543452
    [No Abstract]   [Full Text] [Related]  

  • 24. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001.
    Hall HI; McDavid K; Ling Q; Sloggett A
    Ann Epidemiol; 2006 Nov; 16(11):824-33. PubMed ID: 17067817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment: households and HIV/AIDS.
    Madhavan S
    Scand J Public Health Suppl; 2007 Aug; 69():155-6. PubMed ID: 17676517
    [No Abstract]   [Full Text] [Related]  

  • 27. Are we winning the battle against the human immunodeficiency virus.
    Sullivan AK; Nelson MR
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the heroin epidemic, its impact, its context, and health policy].
    Villalbí JR; Brugal MT
    Med Clin (Barc); 1999 May; 112(19):736-7. PubMed ID: 10394572
    [No Abstract]   [Full Text] [Related]  

  • 29. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fewer AIDS deaths and illnesses: new information.
    James JS
    AIDS Treat News; 1997 Feb; (No 265):1-3. PubMed ID: 11364239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000.
    Lai DJ; Tarwater PM; Hardy RJ
    Public Health; 2006 Jun; 120(6):486-92. PubMed ID: 16730037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the Center for Disease Control and Prevention. Selected data from the HIV/AIDS Surveillance Report through December 1995.
    Pediatr AIDS HIV Infect; 1996 Aug; 7(4):287-304. PubMed ID: 11361723
    [No Abstract]   [Full Text] [Related]  

  • 34. Semiparametric approaches for joint modeling of longitudinal and survival data with time-varying coefficients.
    Song X; Wang CY
    Biometrics; 2008 Jun; 64(2):557-66. PubMed ID: 17725812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The AIDS epidemic widens].
    Gesundheitswesen; 2003 Jun; 65(6):422. PubMed ID: 12903643
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ten years of commitment to persons living with HIV-AIDS: evaluation of the management in three ambulatory treatment centers of the French Red Cross in Africa].
    Mouala C; Madec Y; Adam G; Courpotin C; Fikouma V; Gentilini M; Ould Mohamedoune A; Nzounza P; Schaer E; Simon B; Mattei JF
    Sante; 2008; 18(2):89-95. PubMed ID: 19188132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Censored partial regression.
    Orbe J; Ferreira E; Núñez-Antón V
    Biostatistics; 2003 Jan; 4(1):109-21. PubMed ID: 12925333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Causes of death (1983-1997) in patients infected with human immunodeficiency virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection].
    Fukutake K; Ueda Y; Tatsunami S; Ajisawa A; Oka S; Takamatsu J; Taki M; Shirahata A
    Rinsho Ketsueki; 1999 Jul; 40(7):550-5. PubMed ID: 10483137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
    Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
    Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some demographic consequences of the HIV epidemic in the world: more focus on sub-Saharian Africa].
    Brouard N
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):121-5. PubMed ID: 10804421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.